Roxatidine suppresses inflammatory respo
✍
Eu-Jin Cho; Hyo-Jin An; Ji-Sun Shin; Hye-Eun Choi; Jane Ko; Young-Wuk Cho; Hyung
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 638 KB
Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h